• LAST PRICE
    0.0001
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    --- / 0.0001
  • Day Range
    ---
  • 52 Week Range
    Low 0.0001
    ---
    High 0.0001
  • Volume
    ---

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
Table Data Not Available
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesPLTT
Pilot Therapeutics Holdings Inc
1.2K
0.0x
---
United StatesSIGO
Sunset Island Group Inc
590.0
0.0x
---
United StatesNUNZ
Nunzia Pharmaceutical Corp
430.0
0.0x
---
United StatesGSAC
Gelstat Corp
210.0K
-0.1x
---
United StatesMDCN
Medican Enterprises Inc
38.9K
0.0x
---
United StatesONPH
Oncology Pharma Inc
40.0
0.0x
---
As of 2024-11-26

Company Information

Pilot Therapeutics Holdings, Inc. is a holding company for Pilot Therapeutics, Inc. and is a specialty pharmaceutical company. Through lipid profiling and metabolism, the Company has developed a proprietary, lipid and genomic profiling research platform, termed Functional Liponomics. Using Functional Liponomics, the Company is developing novel, branded, therapeutic, pharmaceutical and over-the-counter (OTC) medical food products that are specifically designed to address dysfunctional lipid metabolism in chronic human diseases such as asthma, coronary heart disease, allergic rhinitis, cancer, cystic acne and rheumatoid arthritis. Pilot expects to launch its first product, Airozin, for adults and children regionally in April 2003 and nationally by 2004.

Contact Information

Headquarters
101 N. Chestnut Street, Suite 102WINSTON SALEM, NC, United States 27101
Phone
336-725-2222
Fax
302-655-5049

Executives

Chairman of the Board
Terrance Little
President
Keith Wakeman
Chief Executive Officer
Ross Consaul
Chief Financial Officer
Steven Greenberg
Chief Technology Officer, Director
Floyd Chilton

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.2K
Revenue (TTM)
$0.00
Shares Outstanding
11.5M
Pilot Therapeutics Holdings Inc does not pay a dividend.
Beta
---
EPS
$-0.54
Book Value
$-0.52
P/E Ratio
0.0x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.